Almstead Zheng Yang

Track

Insider profile

Almstead Zheng Yang's trades of PTC Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
398.63
Quantity 47,378
Value US$4,165,515
Transaction date
Proposed sale
Price
148.82
Quantity 73,082
Value US$675,577
Transaction date
Proposed sale
Price
431.52
Quantity 13,475
Value US$4,160,473
Transaction date
Proposed sale
Price
28.64
Quantity 53
Value US$1,518
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-05 2026-03-05
PrS Proposed sale
47,378
398.63
US$4,165,515 		47,378 398.63 US$4,165,515
2026-02-18 2026-02-18
PrS Proposed sale
73,082
148.82
US$675,577 		73,082 148.82 US$675,577
2026-01-08 2026-01-08
PrS Proposed sale
13,475
431.52
US$4,160,473 		13,475 431.52 US$4,160,473
2026-01-07 2026-01-07
PrS Proposed sale
52
77.48
US$4,029 		52 77.48 US$4,029
2026-01-06 2026-01-06
PrS Proposed sale
54
76.95
US$4,155 		54 76.95 US$4,155
2025-01-08 2025-01-08
PrS Proposed sale
107
44.50
US$4,761 		107 44.50 US$4,761
2025-01-07 2025-01-07
PrS Proposed sale
55
45.34
US$2,494 		55 45.34 US$2,494
2024-12-02 2024-12-02
PrS Proposed sale
2,060
51.98
US$107,070 		2,060 51.98 US$107,070
2024-01-30 2024-01-30
PrS Proposed sale
28
27.25
US$763 		28 27.25 US$763
2024-01-09 2024-01-09
PrS Proposed sale
100
29.01
US$2,901 		100 29.01 US$2,901
2024-01-08 2024-01-08
PrS Proposed sale
53
28.64
US$1,518 		53 28.64 US$1,518